Skip to main content
Hugel, Inc. logo

Hugel, Inc. — Investor Relations & Filings

Ticker · 145020 ISIN · KR7145020004 KO Manufacturing
Open in API
Filings indexed 499 across all filing types
Latest filing 2024-02-08 Report Publication Anno…
Country KR South Korea
Listing KO 145020

About Hugel, Inc.

https://www.hugel-inc.com/

Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) notifying the public of an upcoming investor relations (IR) event, specifically a conference call to discuss 2023 Q4 financial results. It provides the date, time, and location (website) where materials will be posted. According to the 'Menu vs Meal' rule, since this is an announcement of an event/report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2024-02-08 Korean
주식소각결정
Share Issue/Capital Change Classification · 100% confidence The document is an official regulatory announcement regarding a 'Decision to Cancel Shares' (주식소각 결정) by the company Hugel. It details the number of shares to be cancelled, the method (cancellation of treasury shares), and the board resolution date. This falls under the category of capital changes or share-related corporate actions. Since it specifically concerns the cancellation of treasury shares, it aligns with the definition of share capital changes/transactions.
2023-12-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Hugel regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the 23rd Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the record date. Given it is a specific regulatory disclosure regarding meeting logistics, it fits best under the RNS category.
2023-12-15 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings Classification · 95% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Hugel Co., Ltd. under the GS Group. It details information regarding circular shareholding, voting rights of financial/insurance affiliates, and inter-affiliate transactions. These types of regulatory disclosures in South Korea, which provide specific corporate group status updates to the Fair Trade Commission, do not fit into standard financial reporting categories like 10-K or IR. Therefore, it is classified as a general regulatory filing.
2023-11-30 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Hugel, Inc. covering the period from January 1, 2023, to September 30, 2023. It contains comprehensive financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Hugel, detailing quarterly financial performance (Revenue, Operating Profit, Net Income) for the 3rd quarter of 2023. It provides key financial highlights and comparisons to previous periods, which is the standard format for an Earnings Release (ER). It is not a full report, but rather a summary announcement of financial results. Q3 2023
2023-11-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.